Zhongzhu Medical Holdings Co Ltd

600568.CG▼

ST Zhongzhu's 2026 interim report shows net loss widening to 42.2438 million yuan

ST Zhongzhu released its 2026 interim report. Total operating revenue was 259 million yuan, down 14.35% year on year. Net profit attributable to the parent company was a loss of 42.2438 million yuan, an increase in loss of 18.1065 million yuan compared with the same period last year. Net cash inflow from operating activities was 12.218 million yuan, down 71.75% year on year. The company's asset-liability ratio was 19.05%, gross margin was 9.17%, return on equity was negative 2.65%, and diluted earnings per share was negative 0.02 yuan. The number of shareholders was 18,700, and the top ten shareholders held 54.36% of total share capital.

600568.CG ▼

Jiemian·19dRead more →

600568.CG▲2

Prominent Investor Wu Shichun Plans to Increase Stake in ST Zhongzhu by at Least 20 Million Shares

Prominent investor Wu Shichun, the second-largest shareholder of ST Zhongzhu and the actual controller of Meihua Investment, plans to increase his stake in ST Zhongzhu through his controlled entity Meiling Wofei by no less than 20 million shares and no more than 40 million shares, without setting a fixed price range for the increase. Wu Shichun was elected chairman of ST Zhongzhu in April this year and took on the additional role of president at the end of June. The company's office address has been relocated from Zhuhai to Shenzhen. Meihua Investment currently holds 207 million shares of ST Zhongzhu, representing 10.38 percent of the total share capital, while Meiling Wofei does not yet hold any shares. ST Zhongzhu expects a net loss attributable to the parent company of 36 million to 54 million yuan for the first half of the year, with the loss widening by 12 million to 30 million yuan year-on-year, mainly due to the liquidation of its real estate segment and a decline in revenue from its hospital segment.

600568.CG ▲

上海证券报·53dRead more →